These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38577570)

  • 41. Papillary thyroid microcarcinoma: how to diagnose and manage this epidemic?
    Soares P; Celestino R; Gaspar da Rocha A; Sobrinho-Simões M
    Int J Surg Pathol; 2014 Apr; 22(2):113-9. PubMed ID: 24401191
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Active Surveillance Outcomes of Patients with Low-Risk Papillary Thyroid Microcarcinoma According to Levothyroxine Treatment Status.
    Yamamoto M; Miyauchi A; Ito Y; Fujishima M; Sasaki T; Kudo T
    Thyroid; 2023 Oct; 33(10):1182-1189. PubMed ID: 37310904
    [No Abstract]   [Full Text] [Related]  

  • 43. Extensive lymphatic spread of papillary thyroid microcarcinoma is associated with an increase in expression of genes involved in epithelial-mesenchymal transition and cancer stem cell-like properties.
    Lee S; Bae JS; Jung CK; Chung WY
    Cancer Med; 2019 Nov; 8(15):6528-6537. PubMed ID: 31498560
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Position paper from the Japan Thyroid Association task force on the management of low-risk papillary thyroid microcarcinoma (T1aN0M0) in adults.
    Horiguchi K; Yoshida Y; Iwaku K; Emoto N; Kasahara T; Sato J; Shimura H; Shindo H; Suzuki S; Nagano H; Furuya F; Makita N; Matsumoto F; Manaka K; Mitsutake N; Miyakawa M; Yokoya S; Sugitani I
    Endocr J; 2021 Jul; 68(7):763-780. PubMed ID: 33762511
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation.
    Ito Y; Miyauchi A; Kihara M; Higashiyama T; Kobayashi K; Miya A
    Thyroid; 2014 Jan; 24(1):27-34. PubMed ID: 24001104
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Active surveillance for adult low-risk papillary thyroid microcarcinoma-a review focused on the 30-year experience of Kuma Hospital.
    Ito Y; Miyauchi A; Fujishima M; Yamamoto M; Sasaki T
    Endocr J; 2024 Jan; 71(1):7-21. PubMed ID: 37793883
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinicopathological features of papillary thyroid microcarcinoma with a diameter less than or equal to 5 mm.
    Yan L; Blanco J; Reddy V; Al-Khudari S; Tajudeen B; Gattuso P
    Am J Otolaryngol; 2019; 40(4):560-563. PubMed ID: 31103218
    [TBL] [Abstract][Full Text] [Related]  

  • 48. No considerable changes in papillary thyroid microcarcinoma characteristics over a 30-year time period.
    Vlassopoulou V; Vryonidou A; Paschou SA; Ioannidis D; Koletti A; Klonaris N; Katsoulis K; Rontogianni D; Vasilopoulos C; Tsagarakis S; Tzavara I
    BMC Res Notes; 2016 Apr; 9():252. PubMed ID: 27129971
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Cross-Sectional Survey of Patient Treatment Choice in a Multicenter Prospective Cohort Study on Active Surveillance of Papillary Thyroid Microcarcinoma (MAeSTro).
    Hwangbo Y; Choi JY; Lee EK; Ryu CH; Cho SW; Chung EJ; Hah JH; Jeong WJ; Park SK; Jung YS; Kim JH; Kim MJ; Kim SJ; Kim YK; Lee CY; Lee JY; Lee YJ; Yu HW; Park DJ; Ryu J; Park YJ; Lee KE; Moon JH
    Thyroid; 2022 Jul; 32(7):772-780. PubMed ID: 35698288
    [No Abstract]   [Full Text] [Related]  

  • 50. Impact of major different variants of papillary thyroid microcarcinoma on the clinicopathological characteristics: the study of 1041 cases.
    Zhi J; Zhao J; Gao M; Pan Y; Wu J; Li Y; Li D; Yu Y; Zheng X
    Int J Clin Oncol; 2018 Feb; 23(1):59-65. PubMed ID: 28744725
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thermal Ablation for the Management of Papillary Thyroid Microcarcinoma in the Era of Active Surveillance and Hemithyroidectomy.
    Chung SR; Baek JH; Choi YJ; Lee JH
    Curr Oncol Rep; 2022 Aug; 24(8):1045-1052. PubMed ID: 35384589
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased incidence of papillary thyroid microcarcinoma with decreased tumor size of thyroid cancer.
    Lin JD
    Med Oncol; 2010 Jun; 27(2):510-8. PubMed ID: 19507072
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Retrospective comparison of screening criteria for active surveillance for papillary thyroid microcarcinoma].
    Qian K; Sun TQ; Guo K; Zheng XK; Li DS; Wei WW; Wu Y; Ji QH; Wang ZY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):430-434. PubMed ID: 28635215
    [No Abstract]   [Full Text] [Related]  

  • 54. A novel nomogram for identifying high-risk patients among active surveillance candidates with papillary thyroid microcarcinoma.
    Zhang L; Wang P; Li K; Xue S
    Front Endocrinol (Lausanne); 2023; 14():1185327. PubMed ID: 37780614
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Which papillary thyroid microcarcinoma should be treated as "true cancer" and which as "precancer"?
    Kaliszewski K; Diakowska D; Wojtczak B; Forkasiewicz Z; Pupka D; Nowak Ł; Rudnicki J
    World J Surg Oncol; 2019 May; 17(1):91. PubMed ID: 31146753
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical predictors of lymph node metastasis and survival rate in papillary thyroid microcarcinoma: analysis of 3607 patients at a single institution.
    Xu Y; Xu L; Wang J
    J Surg Res; 2018 Jan; 221():128-134. PubMed ID: 29229118
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Active Surveillance of Thyroid Microcarcinomas: a Critical View.
    Cernea CR; Matos LL; Eugênio C; Ferreira GM; Cerqueira YS; Leite AKN; Vanderlei FAB; de Carlucci D; Gotoda RN; Hojaij FC; Araújo-Filho VJF
    Curr Oncol Rep; 2022 Jan; 24(1):69-76. PubMed ID: 35061193
    [TBL] [Abstract][Full Text] [Related]  

  • 58. RISK FACTORS FOR CENTRAL LYMPH NODE METASTASES IN PATIENTS WITH PAPILLARY THYROID MICROCARCINOMA.
    Wu X; Li B; Zheng C; He X
    Endocr Pract; 2018 Dec; 24(12):1057-1062. PubMed ID: 30289307
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cost-effectiveness of active surveillance versus early surgery for thyroid micropapillary carcinoma based on diagnostic and treatment norms in China.
    Lai M; Zhang MM; Qin QQ; An Y; Li YT; Yuan WZ
    Front Endocrinol (Lausanne); 2023; 14():1166433. PubMed ID: 37664842
    [TBL] [Abstract][Full Text] [Related]  

  • 60. US-Guided Radiofrequency Ablation for Low-Risk Papillary Thyroid Microcarcinoma: Efficacy and Safety in a Large Population.
    Lim HK; Cho SJ; Baek JH; Lee KD; Son CW; Son JM; Baek SM
    Korean J Radiol; 2019 Dec; 20(12):1653-1661. PubMed ID: 31854153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.